The investment is intended for the manufacturing of the antidepressant Seroxat and the HIV treatment Retrovir, thediplomat.ro reported.
The company is said to export drugs to more than 80 countries, which is greater than 50 nations at the end of last year.
France and Italy consitute almost 24% of the company’s total exports.